Target Inhibiting the Binding of Cortactin and Arp2/3 Complex Supresses the Invasion and Metastasis of Colon Carcinoma

WU Han,YUAN Daiyue,JIA Xiaobin,QIAN Fei,ZHU Jianwei

DOI: https://doi.org/10.3969/j.issn.1008-6358.2012.06.006

2012-01-01

Abstract:Objective:To evaluate the influence of inhibition of the binding of cortactin and Arp2/3 complex on the invasion and metastasis of colon cancer.Methods:According to the binding domain of cortactin and Arp2/3 complex,the recombinant plasmid(ABR plasmid)was successfully constructed,which contained ABR domain,but without NTA domain.Then ABR plasmid wastransfected into colorectal cancer cell line LoVo.A mouse model of metastatic colon cancer was constructed by injection of LoVo cell line into spleen of mice.Mice were divided into three groups: LoVo group,mice in which were not transfected with the recombinant plasmid;control group,mice in which were transfected with empty plasmid;and the recombinant plasmid transfected group(EGFP/N2/ABR group).Differences in the number,size,and distribution of liver metastatic nodules were compared among the 3 groups.Expression level of galectin-1 was detected.Results: The size and number of metastatic tumors in liver of EGFP/N2/ABR group were significantly smaller than those in LoVo group(P<0.05).The expression of galectin-1 in EGFP/N2/ABR was significantly lower than that in LoVo group(P<0.05).Conclusions: Target inhibiting the binding of cortex protein and Arp2/3 complex can inhibit the invasion and metastasis of colon cancer cell line,which may be achieved through the down-regulating of the expression of galectin-1.